How to manage bleeding risk with serotonin reuptake inhibitor antidepressantsReview examines risk factors and outlines strategies to mitigate bleeding risk New Canadian consensus guidelines for colorectal cancer screeningProvide guidance for individuals with a family history of nonhereditary colorectal cancer or adenoma Health Canada approves rifaximin (Zaxine) for treating irritable bowel syndrome with diarrhea Two-week course reduces common IBS-D symptoms, including bloating, abdominal pain and diarrhea Esomeprazole switching from Schedule II to Schedule III status in Canada To be available for self-selection for once-daily 14-day treatment of frequent heartburn New Canadian guidelines for treatment of Clostridium difficile infection Provide recommendations for the management of initial and recurrent episodes Is ondansetron safe to use during pregnancy? Systematic review examines ondansetron safety for treating nausea and vomiting in pregnancy Can early exposure to anti-TNF therapy reduce the risk of Parkinson disease? Study suggests reducing systemic inflammation in patients with inflammatory bowel disease can also decrease the incidence of Parkinson disease 'Gliptin' use in type 2 diabetes may increase risk of developing inflammatory bowel disease Study authors suggest avoiding DPP-4 inhibitors in patients with a family history of inflammatory bowel disease and monitoring for persistent gastrointestinal symptoms Educational efforts reduce docusate use in hospitalized patients Alberta pharmacists reduce use of stool softener that has limited efficacy in preventing constipation Current management recommendations for Helicobacter pylori infections in adults First Previous 10 11 12 13 14 Next Last
